tiprankstipranks
Ars Pharmaceuticals, Inc. (SPRY)
:SPRY
US Market

ARS Pharmaceuticals (SPRY) Income Statement

Compare
363 Followers

ARS Pharmaceuticals Income Statement

Last quarter (Q3 2024), ARS Pharmaceuticals's total revenue was $2.07M, an increase of Infinity% from the same quarter last year. In Q3, ARS Pharmaceuticals's net income was $-19.13M. See ARS Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 30.00K$ 1.32M$ 5.51M$ 17.84M$ 0.00
Gross Profit
$ -43.00K$ -16.00M$ -14.77M$ 3.77M$ -1.55M
Operating Expenses
$ 67.55M$ 36.83M$ 24.96M$ 18.30M$ 22.52M
Depreciation and Amortization
$ 73.00K$ 319.00K$ 213.00K$ 1.71M$ 1.55M
EBITDA
$ -67.45M$ -35.52M$ -19.24M$ -463.00K$ -22.52M
Operating Income
$ -67.52M$ -35.52M$ -19.45M$ -469.00K$ -24.07M
Other Income/Expenses
$ 13.15M$ 834.00K$ -789.00K$ -596.00K$ 100.00K
Pretax Income
$ -54.37M$ -34.68M$ -20.24M$ -1.06M$ -23.97M
Net Income
$ -54.37M$ -33.99M$ -20.24M$ -1.06M$ -23.97M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.57$ -0.85$ -0.70$ -0.03$ -0.72
Diluted EPS
$ -0.57$ -0.85$ -0.70$ -0.03$ -0.72
Weighted Average Shares Outstanding
95.22M 39.96M 28.87M 34.70M 33.07M
Weighted Average Shares Outstanding (Diluted)
95.22M 39.96M 28.87M 34.70M 33.07M
Currency in USD

ARS Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis